309 related articles for article (PubMed ID: 23834283)
1. Antifungal susceptibility of Malassezia pachydermatis biofilm.
Figueredo LA; Cafarchia C; Otranto D
Med Mycol; 2013 Nov; 51(8):863-7. PubMed ID: 23834283
[TBL] [Abstract][Full Text] [Related]
2. Malassezia pachydermatis from animals: Planktonic and biofilm antifungal susceptibility and its virulence arsenal.
Brilhante RSN; Rocha MGD; Guedes GMM; Oliveira JS; Araújo GDS; España JDA; Sales JA; Aguiar L; Paiva MAN; Cordeiro RA; Pereira-Neto WA; Pinheiro AQ; Sidrim JJC; Castelo-Branco DSCM; Rocha MFG
Vet Microbiol; 2018 Jul; 220():47-52. PubMed ID: 29885800
[TBL] [Abstract][Full Text] [Related]
3. In vitro antifungal susceptibility of Malassezia pachydermatis from dogs with and without skin lesions.
Cafarchia C; Figueredo LA; Iatta R; Montagna MT; Otranto D
Vet Microbiol; 2012 Mar; 155(2-4):395-8. PubMed ID: 21962411
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic characterization and in vitro antifungal sensitivity of Candida spp. and Malassezia pachydermatis strains from dogs.
Brito EH; Fontenelle RO; Brilhante RS; Cordeiro RA; Soares Júnior FA; Monteiro AJ; Sidrim JJ; Rocha MF
Vet J; 2007 Jul; 174(1):147-53. PubMed ID: 17188535
[TBL] [Abstract][Full Text] [Related]
5. Biofilm production and antifungal susceptibility of co-cultured Malassezia pachydermatis and Candida parapsilosis isolated from canine seborrheic dermatitis.
Bumroongthai K; Chetanachan P; Niyomtham W; Yurayart C; Prapasarakul N
Med Mycol; 2016 Jul; 54(5):544-9. PubMed ID: 26868903
[TBL] [Abstract][Full Text] [Related]
6. Azole susceptibility of Malassezia pachydermatis and Malassezia furfur and tentative epidemiological cut-off values.
Cafarchia C; Iatta R; Immediato D; Puttilli MR; Otranto D
Med Mycol; 2015 Sep; 53(7):743-8. PubMed ID: 26162472
[TBL] [Abstract][Full Text] [Related]
7. Antifungal agent susceptibilities and interpretation of Malassezia pachydermatis and Candida parapsilosis isolated from dogs with and without seborrheic dermatitis skin.
Yurayart C; Nuchnoul N; Moolkum P; Jirasuksiri S; Niyomtham W; Chindamporn A; Kajiwara S; Prapasarakul N
Med Mycol; 2013 Oct; 51(7):721-30. PubMed ID: 23547880
[TBL] [Abstract][Full Text] [Related]
8. In vitro evaluation of Malassezia pachydermatis susceptibility to azole compounds using E-test and CLSI microdilution methods.
Cafarchia C; Figueredo LA; Iatta R; Colao V; Montagna MT; Otranto D
Med Mycol; 2012 Nov; 50(8):795-801. PubMed ID: 22471886
[TBL] [Abstract][Full Text] [Related]
9. High multi-azole-resistant Malassezia pachydermatis clinical isolates from canine Malassezia dermatitis.
Kano R; Aramaki C; Murayama N; Mori Y; Yamagishi K; Yokoi S; Kamata H
Med Mycol; 2020 Feb; 58(2):197-200. PubMed ID: 31329927
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and genetic diversity of azole-resistant Malassezia pachydermatis isolates from canine otitis and dermatitis: A 2-year study.
Álvarez-Pérez S; Quevedo-Caraballo S; García ME; Blanco JL
Med Mycol; 2024 May; 62(5):. PubMed ID: 38734886
[TBL] [Abstract][Full Text] [Related]
11. Subculture on potato dextrose agar as a complement to the broth microdilution assay for Malassezia pachydermatis.
Prado MR; Brito EH; Brilhante RS; Cordeiro RA; Leite JJ; Sidrim JJ; Rocha MF
J Microbiol Methods; 2008 Oct; 75(2):341-3. PubMed ID: 18603321
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of carvacrol, cinnamaldehyde and thymol combined with antifungals against Malassezia pachydermatis.
Schlemmer KB; Jesus FPK; Tondolo JSM; Weiblen C; Azevedo MI; Machado VS; Botton SA; Alves SH; Santurio JM
J Mycol Med; 2019 Dec; 29(4):375-377. PubMed ID: 31455580
[TBL] [Abstract][Full Text] [Related]
13. The role of drug efflux pumps in Malassezia pachydermatis and Malassezia furfur defence against azoles.
Iatta R; Puttilli MR; Immediato D; Otranto D; Cafarchia C
Mycoses; 2017 Mar; 60(3):178-182. PubMed ID: 27774659
[TBL] [Abstract][Full Text] [Related]
14. Genotyping and antifungal susceptibility testing of multiple Malassezia pachydermatis isolates from otitis and dermatitis cases in pets: is it really worth the effort?
Álvarez-Pérez S; García ME; Peláez T; Blanco JL
Med Mycol; 2016 Jan; 54(1):72-79. PubMed ID: 26333353
[TBL] [Abstract][Full Text] [Related]
15. Effects of beta-thujaplicin on anti-Malassezia pachydermatis remedy for canine otitis externa.
Nakano Y; Wada M; Tani H; Sasai K; Baba E
J Vet Med Sci; 2005 Dec; 67(12):1243-7. PubMed ID: 16397383
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the antifungal susceptibility of Malassezia pachydermatis in various media using a CLSI protocol.
Cafarchia C; Figueredo LA; Favuzzi V; Surico MR; Colao V; Iatta R; Montagna MT; Otranto D
Vet Microbiol; 2012 Oct; 159(3-4):536-40. PubMed ID: 22622336
[TBL] [Abstract][Full Text] [Related]
17. In vitro antifungal susceptibility of Malassezia pachydermatis strains isolated from dogs with chronic and acute otitis externa.
Chiavassa E; Tizzani P; Peano A
Mycopathologia; 2014 Oct; 178(3-4):315-9. PubMed ID: 25031085
[TBL] [Abstract][Full Text] [Related]
18. In vitro combination of antifungal agents against Malassezia pachydermatis.
Schlemmer KB; de Jesus FPK; Loreto ES; Farias JB; Alves SH; Ferreiro L; Santurio JM
Med Mycol; 2019 Apr; 57(3):324-327. PubMed ID: 29924372
[TBL] [Abstract][Full Text] [Related]
19. In vitro antifungal activity of topical and systemic antifungal drugs against Malassezia species.
Carrillo-Muñoz AJ; Rojas F; Tur-Tur C; de Los Ángeles Sosa M; Diez GO; Espada CM; Payá MJ; Giusiano G
Mycoses; 2013 Sep; 56(5):571-5. PubMed ID: 23496653
[TBL] [Abstract][Full Text] [Related]
20. An azole-resistant isolate of Malassezia pachydermatis.
Nijima M; Kano R; Nagata M; Hasegawa A; Kamata H
Vet Microbiol; 2011 Apr; 149(1-2):288-90. PubMed ID: 21074337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
